
Despite heightened cardiovascular disease (CVD) risk, too few get drugs at appropriate dose, researchers say.
Brian P. Dunleavy has been covering health and medical research for more than 25 years, for United Press International and EverydayHealth.com, among other outlets. He is also the former editor of Infectious Disease Special Edition. In addition, he has written on other subjects for Biography.com, History.com, the Village Voice and amNewYork, among others. He holds a master’s degree from the University of Missouri School of Journalism.

Despite heightened cardiovascular disease (CVD) risk, too few get drugs at appropriate dose, researchers say.

JAMA study highlights more reluctance among communities of color.

Fewer than 10,000 adverse events among more than 8.9 million doses administered.

Patients failed to respond to currently available drugs in initial documented instances of spread.

Patients given a 600 mg injection of cabotegravir still had detectable levels of the drug in plasma, tissues, and fluids for 12 weeks.

CDC report chronicles 20 incidents of HBV infection among recipients between 2014 and 2019.

This serious adverse event has been linked with COVID-19 shots from AstraZeneca and Janssen.

New study finds differences in testing, disease severity in England.

Modeling studies highlight best approaches for schools in the coming academic year.

Smithsonian researchers lead charge for enhanced method to identify pathogen threats before they emerge from natural environment.

Analysis of medications used in California hospitals over the course of 2020 highlights “evidence-based decisions.”

New shot fills a vital need, given poor efficacy of earlier options, researchers say.

Studies are in early stages, according to the scientists at Rensselaer Polytechnic Institute (RPI) leading them.

Protection from “natural infection” may last longer in older adults, authors say.

Surveys suggest most students plan to get the shots anyway.

CDC report highlights disparities among “racial, ethnic, gender, and sexual” minorities.

Providing support to communities of color could encourage participation and improve uptake.

Letters to legislators call for increased funding to address ongoing crisis.

Reproduction number should govern allocation of the shot, researchers say.

New drugs likely won’t meet resistance challenges ahead, authors say.

New World Obesity Foundation report finds higher COVD-19 mortality rates in countries with higher prevalence of obesity.

Study results highlight that new data is constantly emerging and that society must be flexible in its response to the pandemic.

Ruth Coker Burks’ new book, All the Young Men, chronicles her years at the bedside of victims.

New CDC guidance highlights the importance of shingles vaccine, yet numbers suggest demand for it may be on decline.

Study outlines differences in health, access to care, among other factors.

A study's findings could and should shape vaccine distribution, the authors say.

A £100 million donation from Ineos will fund collaborative effort across sciences.

This assertion is made of filmmakers who documented it as well as a new study has found evidence of antibodies in blood samples collected in Wuhan, suggesting recent infection.

Findings run counter to positive media coverage of Merkel, Ardern, and others.

Nearly 20% of patients who survive hospitalization are readmitted within 60 days, researchers find.